14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of BLRX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Wednesday for BioLineRx Ltd. stock after losing 3.74%
(Updated on Apr 24, 2024)

Sell candidate since Mar 25, 2024 Loss -52.85% PDF

The BioLineRx Ltd. stock price fell by -3.74% on the last day (Wednesday, 24th Apr 2024) from $0.637 to $0.613. During the last trading day the stock fluctuated 7.02% from a day low at $0.591 to a day high of $0.632. The price has fallen in 6 of the last 10 days and is down by -16.68% for this period. Volume has increased on the last day by 336 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 759 thousand shares were bought and sold for approximately $465.15 thousand.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.575 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -32.69% during the next 3 months and, with a 90% probability hold a price between $0.387 and $0.792 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

BLRX Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The BioLineRx Ltd. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.641 and $0.94. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, April 22, 2024, and so far it has fallen -9.47%. Further fall is indicated until a new bottom pivot has been found. BioLineRx Ltd. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for BioLineRx Ltd. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0415 between high and low, or 7.02%. For the last week, the stock has had daily average volatility of 7.91%.

BioLineRx Ltd. is oversold on RSI14 (24). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BLRX) For The Upcoming Trading Day Of Thursday 25th

For the upcoming trading day on Thursday, 25th we expect BioLineRx Ltd. to open at $0.612, and during the day (based on 14 day Average True Range), to move between $0.539 and $0.687, which gives a possible trading interval of +/-$0.0740 (+/-12.08%) up or down from last closing price. If BioLineRx Ltd. takes out the full calculated possible swing range there will be an estimated 24.16% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $0.700, some $0.0870 (14.19%) from the current price of $0.613, our system finds the risk reward not very attractive.

Is BioLineRx Ltd. stock A Buy?

BioLineRx Ltd. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -6.859 Strong Sell Candidate Unchanged

Predicted Opening Price for BioLineRx Ltd. of Thursday, April 25, 2024

Fair opening price April 25, 2024 Current price
$0.612 ( 0.158%) $0.613

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for BLRX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.654 6.61 %
R2 0.638 4.03 %
R1 0.628 2.43 %
Current price: 0.613
Support S1 0.596 -2.74 %
S2 0.586 -4.34 %
S3 0.571 -6.93 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.736 20.02 %
R2 0.708 15.42 %
R1 0.700 14.19 %
Current price 0.613
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for BioLineRx Ltd. Stock and on which exchange is it traded?
The symbol for BioLineRx Ltd. is BLRX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell BioLineRx Ltd. Stock?
BioLineRx Ltd. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy BioLineRx Ltd. Stock?
BioLineRx Ltd. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy BioLineRx Ltd. Stock.

What's the current price of BioLineRx Ltd. Stock?
As of the end of day on the Apr 24, 2024, the price of an BioLineRx Ltd. (BLRX) share was $0.613.

What is the 52-week high and low for BioLineRx Ltd. Stock?
The 52-week high for BioLineRx Ltd. Stock is $2.53 and the 52-week low is $0.591.

What is the market capitalization of BioLineRx Ltd. Stock?
As of the Apr 24, 2024, the market capitalization of BioLineRx Ltd. is 52.094M.

When is the next earnings date for BioLineRx Ltd.?
The upcoming earnings date for BioLineRx Ltd. is May 22, 2024.
Click to get the best stock tips daily for free!

About BioLineRx Ltd.

BioLineRx Ltd. BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company develops Motixafortide, a peptide, which has completed Phase 3 clinical trials for the treatment of autologous stem cell mobilization and Phase 2a clinical trials for the treatment of pancreatic cancer; and that is in Phase 2 clinical trials for the treatment of metastatic pancreatic adenocarcinoma patients, and Phase 1b clinical trials in pat... BLRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT